Monteverde, Ezequiel
Diehl, María
Saieg, Magdalena
Beauchamp, María
Castellini, Jorge Luis Alberto
Neira, Jorge Alberto
Klappenbach, Roberto Félix
Rey, Paula
Mirofsky, Matías
Quintana, Rosana
Boietti, Bruno Rafael
Zanchetta, María Belén
Giacoia, Evangelina
Lartigue, Betina
Abbate, Ana Silvina
Medina, Arnaldo
Matassa, Verónica Silvina
Olivetto, Roberto
Dodero, Romina
Maglio, Ignacio
Bordes, Mercedes
Nemerovsky, Julio
Bosque, Laura
Article History
Received: 9 June 2022
Accepted: 2 September 2022
First Online: 13 September 2022
Declarations
:
: Ezequiel Monteverde, Magdalena Saieg, María Beauchamp, Jorge Luis Alberto Castellini, Jorge Alberto Neira, Roberto Félix Klappenbach, Matías Mirofsky, Rosana Quintana, Betina Lartigue, Ana Silvina Abbate, Arnaldo Medina, Verónica Silvina Matassa, Roberto Olivetto, Romina Dodero, Ignacio Maglio, Mercedes Bordes, Julio Nemerovsky, and Laura Bosque declare not having any conflict of interest. María Diehl is the PI of an ongoing research project that receives funding from AMGEN. Paula Rey received speaker fees from Raffo, AMGEN, Lafage, and Tecnofarma. Bruno Boietti won a research grant from AMGEN in 2019. At present, he is not receiving any financial support from any osteoporosis-related company. María Belén Zanchetta received speaker fees from Raffo, AMGEN, and Ultragenyx. Evangelina Giacoia received fees from AMGEN as an advisory board member and speaker.
Free to read: This content has been made available to all.